ArrowMark Colorado Holdings’s Inhibrx INBX Stock Holding History

ArrowMark Colorado Holdings’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.33M	Hold	35,176	–	–	0.14%	206
2026 Q1	$2.36M	Hold	35,176	–	–	0.06%	214
2025 Q4	$2.78M	Hold	35,176	–	–	0.06%	223
2025 Q3	$1.18M	Sell	35,176 -1,030	-3%	-$25.4K	0.02%	248
2025 Q2	$517K	Sell	36,206 -103,476	-74%	-$1.34M	0.01%	271
2025 Q1	$1.95M	Sell	139,682 -21,217	-13%	-$288K	0.03%	229
2024 Q4	$2.48M	Buy	160,899 +3,852	+2%	+$58.7K	0.03%	226
2024 Q3	$2.46M	Buy	157,047 +4,888	+3%	+$68.7K	0.03%	221
2024 Q2	$2.16M	Buy	+152,159	New	+$2.38M	0.03%	238

Other funds holding INBX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ArrowMark Colorado Holdings's INBX Position: Q2 2026 in Review

ArrowMark Colorado Holdings held its Inhibrx (INBX) position steady in Q2 2026 at 35,176 shares worth $3.33M. The position accounts for 0.14% of the portfolio, ranked #206.

ArrowMark Colorado Holdings first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

ArrowMark Colorado Holdings held 35,176 shares of Inhibrx worth $3.33M as of Q2 2026.
ArrowMark Colorado Holdings left its Inhibrx share count unchanged in Q2 2026.
Inhibrx made up 0.14% of ArrowMark Colorado Holdings's portfolio in Q2 2026, its #206 holding.
ArrowMark Colorado Holdings first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.